Development of fast-disintegrating pellets in a rotary processor

Drug Development and Industrial Pharmacy

Volumn 28, Issue 10, 2002, Pages 1201-1212

  Kristensen, Jakob ^a   Schæfer, Torben ^a   Kleinebudde, Peter ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Bentonite; Disintegrating pellets; Dissolution; Kaolin; Rotary processor

Indexed keywords

BENTONITE; CROSPOVIDONE; EXCIPIENT; KAOLIN; LACTOSE; MICROCRYSTALLINE CELLULOSE; CELLULOSE;

ADHESION; ARTICLE; DENSITY; DRUG FORMULATION; DRUG SOLUBILITY; PARTICLE SIZE; PHARMACEUTICAL ENGINEERING; PHYSICAL CHEMISTRY; SURFACE PROPERTY; WATER CONTENT; CHEMISTRY; METHODOLOGY; PHARMACEUTICS;

BENTONITE; CELLULOSE; CHEMISTRY, PHARMACEUTICAL; EXCIPIENTS; KAOLIN; TECHNOLOGY, PHARMACEUTICAL;

EID: 0036447118     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120015353     Document Type: Article

References (28)

1. Vertommen, J.; Kinget, R. The influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor. Drug Dev. Ind. Pharm. 1997, 23 (1), 39-46.
2. Holm, P.; Bonde, M.; Wigmore, T. Pelletization by granulation in a roto-processor RP-2. Part 1. Effects of process and product variables on granule growth. Pharm. Technol. Eur. 1996, 8 (8), 22-36.
3. Kristensen, J.; Schaefer, T.; Kleinebudde, P. Direct pelletization in a rotary processor controlled by torque measurements. I: Influence of process variables. Pharm. Dev. Technol. 2000, 5 (2), 247-256.
4. Kleinebudde, P. Shrinking and swelling properties of pellets containing microcrystalline cellulose and low substituted hydroxypropylcellulose: II. Swelling properties. Int. J. Pharm. 1994, 109 (Sep 5), 221-227.
5. Kleinebudde, P. Crystallite-gel-model for microcrystalline cellulose in wet-granulation, extrusion, and spheronization. Pharm. Res. 1997, 14 (Jun), 804-809.
6. Ghebre-Sellassie, I. Pharmaceutical Pelletization Technology; Marcel Dekker: New York, 1989.
7. Kleinebudde, P, Shrinking and swelling properties of pellets containing microcrystalline cellulose (MCC) and low substituted hydroxypropylcellulose (L-HPC): I. Shrinking properties. Int. J. Pharm, 1994, 109 (Sep 5), 209-219.
8. Vertommen, J.; Kinget, R, Influence of five selected processing and formulation variables on the release of riboflavin from pellets produced in a rotary processor, STP Pharma Sci. 1996, 6 (5), 335-340.
9. Ek, R.; Newton, J.M. Microcrystalline cellulose as a sponge as an alternative concept to the crystallite-gel model for extrusion and spheronization. Pharm, Res. 1998, 15 (4), 509-512.
10. , Fielden, K.E.; Newton, J.M.; O'Brien, P.; Rowe, R,C R.C, Thermal Studies of the Interactions of Water and Microcrystalline Cellulose. J. Pharm. Pharmacol. 1988, 40, 674-678.
11. Lövgren, K. Disintegrants and fillers in the manufacture of spheres - Their influence on dissolution rates and binding properties. Labo-Pharma - Probl. Tech. 1984, 32 (339), 110-114.
12. , Lövgren, K.; Bogentoft, C. Influence of different disintegrants on the dissolution rate and hardness of furosemide granules prepared by spheronization technique. Acta Pharm. Suec. 1981, 18, 108-109.
13. Schröder, M.; Kleinebudde, P. Influence of formulation parameters on dissolution of propyphenazone pellets. Eur, J. Pharm, Biopharm. 1995, 41 (6), 382-387.
14. Nürnberg, E.; Wunderlich, J, Manufacturing pellets by extrusion and spheronization (Part II). Pharm, Technol. Eur. 1999, 11 (3), 30-34.
15. Neumerkel, O.; Sakr, A.; Suæss, W. Studies of the production and testing of fluidized-bed rotor granules with modified release. Pharmazie 1999, 54 (11), 837-839.
16. Schröder, M.; Kleinebudde, P. Development of disintegrating pellets obtained from extrusion/spheronization. Pharm. Sci. 1995, 1, 415-418.
17. Lövgren, K. Pellet Preparation, In Industrial Aspects of Pharmaceutics; Sandell, E., Ed.; Swedish Pharmaceutical Press: Stockholm, 1993; 210.
18. Otsuka, M.; Gao, J.; Matsuda, Y. Effect of amount of added water during extrusion-spheronization process on pharmaceutical properties of granules. Drug Dev. Ind. Pharm. 1994, 20 (19), 2977-2992.
19. Scheler, S.; Nürnberg, E. Optimierung eines sphäronisatíonsprozesses für die herstellung lipase-haltige extrusionpellets mittels faktorieller versuchsplanung. Pharm. Ind. 2000, 62 (3), 236-242.
20. Basit, A.W.; Newton, J.M.; Lacey, L.F. Formulation of ranitidine pellets by extrusion-spheronization with little or no microcrystalline cellulose. Pharm. Dev. Technol. 1999, 4 (4), 499-505.
21. Fielden, K.E.; Newton, J.M. Extrusion and extruders. In Encyclopedia of Pharmaceutical Technology; Swarbrick, J., Boylan, J.C., Eds.; Marcel Dekker: New York, 1992; Vol. 5, 395-442.
22. Harwood, R.J.; Luber, J.R.; Sunbery, E.W. Antacids and clay products. In Pharmaceutical Dosage Forms - Disperse Systems; Liebermann, H.A., Rieger, M.M., Banker, G.S., Eds.; Marcel Dekker: New York, 1989; 205-229.
23. Kibbe, A.H. Handbook of Pharmaceutical Excipients, 3rd Ed.; Pharmaceutical Press: London, 2000.
24. Law, M.F.L.; Deasy, P.B. Effects of common classes of excipients on extrusion-spheronization. J. Microencaps. 1997, 14 (5), 647-657.
25. European Pharmacopoeia, 3rd Ed.; Council of Europe: Strasbourg, 1997.
26. Johansen, A.; Schæfer, T. Effects of interactions between powder particle size and binder viscosity on agglomerate growth mechanisms in a high shear mixer, Eur. J. Pharm. Sci. 2001, 12, 297-309.
27. Kristensen, J.; Schaefer, T.; Kleinebudde, P. Direct pelletization in a rotary processor controlled by torque measurement. II: Effect of changes in the content of microcrystalline cellulose. AAPS Pharm. Sci. 2000, 2 (3), article 24 (http://www.pharmsci.org/).
28. Gordon, M.S.; Rudraraju, V.S.; Dani, K.; Chowhan, Z.T. Effects of the mode of super disintegrant incorporation on dissolution in wet granulated tablets. J. Pharm. Sci. 1993, 82 (2), 220-226.